Recent publications

The efficacy of antimalarial monotherapies, sulphadoxine-pyrimethamine and amodiaquine in East Africa: implications for sub-regional policy.East African Network for Monitoring Antimalarial, Treatment
Trop Med Int Health, (2003). 8:860-7

Scaling-up coverage with insecticide-treated nets against malaria in Africa: who should pay?.Curtis, C. Maxwell, C. Lemnge, M. Kilama, W. L. Steketee, R. W. Hawley, W. A. Bergevin, Y. Campbell, C. C. Sachs, J. Teklehaimanot, A. Ochola, S. Guyatt, H. Snow, R. W.
Lancet Infect Dis, (2003). 3:304-7

Neuro-cognitive impairment following acquired central nervous system infections in childhood: a systematic review.Carter, J. A. Neville, B. G. Newton, C. R.
Brain Res Brain Res Rev, (2003). 43:57-69

Speech and language sequelae of severe malaria in Kenyan children.Carter, J. A. Murira, G. M. Ross, A. J. Mung'ala-Odera, V. Newton, C. R.
Brain Inj, (2003). 17:217-24

Population genetic structure of the African malaria mosquito Anopheles funestus in Kenya.Braginets, O. P. Minakawa, N. Mbogo, C. M. Yan, G.
Am J Trop Med Hyg, (2003). 69:303-8

Antimalarial chemotherapy: young guns or back to the future?.Biagini, G. A. O'Neill, P. M. Nzila, A. Ward, S. A. Bray, P. G.
Trends Parasitol, (2003). 19:479-87

Prognostic indicators of early and late death in children admitted to district hospital in Kenya: cohort study.Berkley, J. A. Ross, A. Mwangi, I. Osier, F. H. Mohammed, M. Shebbe, M. Lowe, B. S. Marsh, K. Newton, C. R.
BMJ, (2003). 326:361

The use of formal and informal curative services in the management of paediatric fevers in four districts in Kenya.Amin, A. A. Marsh, V. Noor, A. M. Ochola, S. A. Snow, R. W.
Trop Med Int Health, (2003). 8:1143-52

Seroepidemiology of hepatitis B virus in Addis Ababa, Ethiopia: transmission patterns and vaccine control.Abebe, A. Nokes, D. J. Dejene, A. Enquselassie, F. Messele, T. Cutts, F. T.
Epidemiol Infect, (2003). 131:757-70

Clinical status and implications of antimalarial drug resistance.Winstanley, P. A. Ward, S. A. Snow, R. W.
Microbes Infect, (2002). 4:157-64

The membrane characteristics of Plasmodium falciparum-infected and -uninfected heterozygous alpha(0)thalassaemic erythrocytes.Williams, T. N. Weatherall, D. J. Newbold, C. I.
Br J Haematol, (2002). 118:663-70

Challenges in managing profound hypokalaemia.Welfare, W. Sasi, P. English, M.
BMJ, (2002). 324:269-70

Malaria and the red cell.Weatherall, D. J. Miller, L. H. Baruch, D. I. Marsh, K. Doumbo, O. K. Casals-Pascual, C. Roberts, D. J.
Hematology Am Soc Hematol Educ Program, (2002). :35-57

Treatment and prevention of malaria..Warrell, D. A. Watkins, W. M.
Bruce Chwatt’s Essential Malariology, (2002). :268-313

Will the Global Fund help roll back malaria in Africa?.Teklehaimanot, A. Snow, R. W.
Lancet, (2002). 360:888-9

Sources of variability in sequelae of very low birth weight.Taylor, H. G. Burant, C. J. Holding, P. A. Klein, N. Hack, M.
Child Neuropsychol, (2002). 8:163-78

Intensity of malaria transmission, antimalarial-drug use and resistance in Uganda: what is the relationship between these three factors?.Talisuna, A. O. Langi, P. Bakyaita, N. Egwang, T. Mutabingwa, T. K. Watkins, W. Van Marck, E. D'Alessandro, U.
Trans R Soc Trop Med Hyg, (2002). 96:310-7

Role of the pfcrt codon 76 mutation as a molecular marker for population-based surveillance of chloroquine (CQ)-resistant Plasmodium falciparum malaria in Ugandan sentinel sites with high CQ resistance.Talisuna, A. O. Kyosiimire-Lugemwa, J. Langi, P. Mutabingwa, T. K. Watkins, W. Van Marck, E. Egwang, T. D'Alessandro, U.
Trans R Soc Trop Med Hyg, (2002). 96:551-6

Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial.Sulo, J. Chimpeni, P. Hatcher, J. Kublin, J. G. Plowe, C. V. Molyneux, M. E. Marsh, K. Taylor, T. E. Watkins, W. M. Winstanley, P. A.
Lancet, (2002). 360:1136-43

The consequences of reducing transmission of Plasmodium falciparum in Africa.Snow, R. W. Marsh, K.
Adv Parasitol, (2002). 52:235-64